Baotou Dongbao Bio-Tech Co Ltd
Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen and their derivative products in the People's Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private la… Read more
Baotou Dongbao Bio-Tech Co Ltd (300239) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.19 Million) by net assets (CN¥1.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Baotou Dongbao Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Baotou Dongbao Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PHARMANUTRA S.P.A.
F:761
|
N/A |
|
YALLA GROUP SP.ADS/1 CL.A
F:80Q
|
N/A |
|
PWR Holdings Limited
PINK:PWRHF
|
0.100x |
|
PetroVietnam Power Nhon Trach 2 JSC
VN:NT2
|
0.117x |
|
Gedik Yatirim Menkul Degerler AS
IS:GEDIK
|
-0.435x |
|
Whirlpool of India Limited
NSE:WHIRLPOOL
|
0.143x |
|
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
|
0.005x |
|
Danal Co. Ltd
KQ:064260
|
-0.042x |
Annual Cash Flow Conversion Efficiency for Baotou Dongbao Bio-Tech Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.74 Billion | CN¥69.13 Million | 0.040x | -62.26% |
| 2023-12-31 | CN¥1.89 Billion | CN¥199.39 Million | 0.105x | -5.32% |
| 2022-12-31 | CN¥1.76 Billion | CN¥195.32 Million | 0.111x | +246.38% |
| 2021-12-31 | CN¥1.60 Billion | CN¥51.50 Million | 0.032x | -49.22% |
| 2020-12-31 | CN¥998.18 Million | CN¥63.13 Million | 0.063x | +250.67% |
| 2019-12-31 | CN¥991.86 Million | CN¥-41.63 Million | -0.042x | -152.53% |
| 2018-12-31 | CN¥750.88 Million | CN¥60.00 Million | 0.080x | +1970.83% |
| 2017-12-31 | CN¥729.75 Million | CN¥-3.12 Million | -0.004x | -107.57% |
| 2016-12-31 | CN¥718.86 Million | CN¥40.54 Million | 0.056x | -12.57% |
| 2015-12-31 | CN¥706.55 Million | CN¥45.57 Million | 0.065x | +279.51% |
| 2014-12-31 | CN¥340.56 Million | CN¥-12.24 Million | -0.036x | -239.04% |
| 2013-12-31 | CN¥351.47 Million | CN¥9.08 Million | 0.026x | +53.46% |
| 2012-12-31 | CN¥324.03 Million | CN¥5.46 Million | 0.017x | -79.42% |
| 2011-12-31 | CN¥295.99 Million | CN¥24.22 Million | 0.082x | -15.71% |
| 2010-12-31 | CN¥122.44 Million | CN¥11.88 Million | 0.097x | -29.35% |
| 2009-12-31 | CN¥100.65 Million | CN¥13.83 Million | 0.137x | +422.49% |
| 2008-12-31 | CN¥97.87 Million | CN¥-4.17 Million | -0.043x | -- |